Stifel Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.4K | Sell |
70,026
-834
| -1% | -$1.49K | ﹤0.01% | 3541 |
|
|
2025
Q4 | $133K | Buy |
70,860
+16,151
| +30% | +$31K | ﹤0.01% | 3452 |
|
|
2025
Q3 | $70K | Sell |
54,709
-2,403
| -4% | -$3.25K | ﹤0.01% | 3472 |
|
|
2025
Q2 | $70.8K | Sell |
57,112
-2,420
| -4% | -$2.79K | ﹤0.01% | 3387 |
|
|
2025
Q1 | $70.3K | Sell |
59,532
-7,999
| -12% | -$12.3K | ﹤0.01% | 3320 |
|
|
2024
Q4 | $124K | Buy |
67,531
+16,843
| +33% | +$32.9K | ﹤0.01% | 3231 |
|
|
2024
Q3 | $86.2K | Buy |
50,688
+6,129
| +14% | +$10.1K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $61K | Sell |
44,559
-11,515
| -21% | -$23.3K | ﹤0.01% | 3262 |
|
|
2024
Q1 | $210K | Sell |
56,074
-77,800
| -58% | -$456K | ﹤0.01% | 3080 |
|
|
2023
Q4 | $1.31M | Buy |
133,874
+37,556
| +39% | +$307K | ﹤0.01% | 1973 |
|
|
2023
Q3 | $804K | Buy |
96,318
+11,219
| +13% | +$128K | ﹤0.01% | 2190 |
|
|
2023
Q2 | $1.13M | Sell |
85,099
-864
| -1% | -$10.5K | ﹤0.01% | 2007 |
|
|
2023
Q1 | $995K | Sell |
85,963
-16,685
| -16% | -$166K | ﹤0.01% | 2065 |
|
|
2022
Q4 | $840K | Sell |
102,648
-5,416
| -5% | -$46.7K | ﹤0.01% | 2131 |
|
|
2022
Q3 | $627K | Buy |
108,064
+10,310
| +11% | +$59.2K | ﹤0.01% | 2294 |
|
|
2022
Q2 | $432K | Buy |
97,754
+7,185
| +8% | +$43.7K | ﹤0.01% | 2553 |
|
|
2022
Q1 | $824K | Buy |
90,569
+25,316
| +39% | +$291K | ﹤0.01% | 2255 |
|
|
2021
Q4 | $1.33M | Sell |
65,253
-62,514
| -49% | -$1.51M | ﹤0.01% | 1907 |
|
|
2021
Q3 | $3.26M | Sell |
127,767
-1,160
| -0.9% | -$34.4K | ﹤0.01% | 1263 |
|
|
2021
Q2 | $4.51M | Buy |
128,927
+19,903
| +18% | +$579K | 0.01% | 1073 |
|
|
2021
Q1 | $3.63M | Buy |
109,024
+73,343
| +206% | +$2.57M | 0.01% | 1141 |
|
|
2020
Q4 | $926K | Buy |
+35,681
| New | +$606K | ﹤0.01% | 1900 |
|
Other funds holding PACB
AIM
VCM
NAMA
